Analyse-Technique.net - Toutes les news de l'analyse technique


Categories


Tags

surveyed,neurologists,awareness,of,merck,seronoemd,seronos,oral,cladribine,is,double,that,of,novartismitsubishi Surveyed Neurologists' Awareness of Merck Serono/EMD Serono's Oral Cladribine is Double that of Novartis/Mitsubishi ...
WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists have low awareness of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia) among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS). According to the new report, Brand Perception ...
2010-07-15 - redOrbit